Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study

Fig. 4

The mean changes in treatment satisfaction score for one year. Patient satisfaction questionnaire assessments were performed with a Likert scale model with five questions. Mean change in the satisfaction score from baseline was − 1.11 at 3 months (p = 0.54) and − 2.47 at 12 months (p = 0.22)

Back to article page